Pembrolizumab-induced Stevens–Johnson syndrome in non-melanoma patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pembrolizumab-induced Stevens–Johnson syndrome in non-melanoma patients

Published:2017-08 Issue: Volume:81 Page:237-239
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Saw Stephanie^ORCID,Lee Haur Yueh^ORCID,Ng Quan Sing

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference9 articles.

1. Toxic epidermal necrolysis-like reaction with severe satellite cell necrosis associated with nivolumab in a patient with ipilimumab refractory metastatic melanoma;Nayar;J Immunother,2016

2. Epidermal anti-programmed cell death-ligand 1 expression in TEN associated with nivolumab therapy;Vivar;J Cutan Pathol,2017

3. Activity and safety of radiotherapy with anti-PD-1 drug therapy in patients with metastatic melanoma;Liniker;Oncoimmunology,2016

4. Cytotoxic cutaneous adverse drug reactions during anti-PD-1 therapy;Goldinger;Clin Cancer Res,2016

5. Cutaneous adverse events of anti-programmed cell death (PD)-1 therapy in patients with metastatic melanoma: a single-institution cohort;Hwang;J Am Acad Dermatol,2016

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stevens-Johnson syndrome and toxic epidermal necrolysis associated with immune checkpoint inhibitors: a systematic review;Frontiers in Immunology;2024-07-12

2. Oral and cutaneous immune‐related adverse events in cancer patients: Prevalence and overall survival;Oral Diseases;2024-06-27

3. Emerging Insights into Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Induced by Immune Checkpoint Inhibitor and Tumor-Targeted Therapy;Journal of Inflammation Research;2024-04

4. Cardiovascular events after cancer immunotherapy as oncologic emergencies: Analyses of 610 head and neck cancer patients treated with immune checkpoint inhibitors;Head & Neck;2023-12-27

5. Pembrolizumab-induced Stevens-Johnson syndrome/Toxic Epidermal Necrolysis in a Vietnamese patient with nonsmall-cell lung cancer;Asia Pacific Allergy;2023-12-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3